Daunorubicin induced blue-gray hyperpigmentation: A case report

Basit Öğe Kaydı
dc.contributor.authorAyyildiz O.
dc.contributor.authorŞit D.
dc.contributor.authorSöker M.
dc.contributor.authorKadiro?lu A.K.
dc.contributor.authorYeşilba?dan A.H.
dc.date.accessioned2024-04-24T17:58:33Z
dc.date.available2024-04-24T17:58:33Z
dc.date.issued2005
dc.departmentDicle Üniversitesien_US
dc.description.abstractDaunorubicin is used widely in the treatment of acute myeloblastic leukemia (AML). Daunorubicin has some toxicity which limit the usage of drug. Blue-gray pigmentation is an uncommon side effect of daunorubicin. It is one of the side effect which might disturb patient for a long time cosmetically. We report here a hyperpigmentation case with acute myelomonocytic leukemia who is still on the treatment.en_US
dc.identifier.endpage152en_US
dc.identifier.issn1306-133X
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-33646480217
dc.identifier.scopusqualityQ4
dc.identifier.startpage149en_US
dc.identifier.urihttps://hdl.handle.net/11468/23987
dc.identifier.volume15en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofUHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBlue-Gray Pigmentationen_US
dc.subjectDaunorubicinen_US
dc.titleDaunorubicin induced blue-gray hyperpigmentation: A case reporten_US
dc.titleDaunorubicin induced blue-gray hyperpigmentation: A case report
dc.title.alternativeDaunorubisin'e ba?li blue-gray hiperpigmentasyon: Bir olgu sunumuen_US
dc.title.alternativeDaunorubisin'e ba?li blue-gray hiperpigmentasyon: Bir olgu sunumu
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu